MedTrace Logo

Intracoronary Stem Cells in Large Myocardial Infarction

NCT00389545 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2006-10-19

No results posted yet for this study

Summary

Despite the widespread use of effective reperfusion therapies, the patients presenting late with large myocardial infarction have poor outcomes. The aim of the study was to investigate the safety and efficacy of intracoronary injection of autologous bone marrow-derived mononuclear cells (BMNCs) in patients with large myocardial infarction

Conditions

Interventions

PROCEDURE

Intracoronary infusion of autologous bone-marrow derived stem cells

Sponsors & Collaborators

  • Charles University, Czech Republic

    lead OTHER

Principal Investigators

  • Martin Penicka · Charles University, Prague, Czech Republic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00389545 on ClinicalTrials.gov